Colonial Life launches new coverage for COVID-19

2020 SEP 08 (NewsRx) -- By a News Reporter-Staff News Editor at CDC & FDA Daily -- America’s workers concerned about the financial impact of treatment for COVID-19 and other infectious diseases have a new option for protection.

Colonial Life released a new group critical illness plan with an optional rider that offers a lump sum benefit for hospitalization for treatment of COVID-19 and more than a dozen other infectious diseases such as antibiotic-resistant bacteria, Legionnaires’ disease, meningitis, Lyme disease and sepsis.

Colonial Life’s new group critical illness plan has a flexible plan design with a wide range of face amounts to meet different needs. Coverage is available for up to 56 different serious conditions and treatment procedures, including heart attack, stroke, cancer, organ failure or coronary artery bypass graft surgery. Additional conditions covered for children at no additional cost include Down syndrome, cystic fibrosis, cerebral palsy, spina bifida and cleft lip or palate. Employees can further personalize their coverage with riders that provide additional benefits for infectious diseases, cancer, first diagnosis, heart procedures and progressive diseases such as Alzheimer’s disease.

“When life takes an unexpected turn, your focus should be on recovery, not paying the bills,” said Pam Jenkins, assistant vice president for product development at Colonial Life. “Even employees with good health insurance can face significant expenses from copays, deductibles and nonmedical costs related to a serious illness. Group critical illness insurance helps relieve financial worries by providing a lump-sum benefit payable directly to you to use as needed.”

(Our reports deliver fact-based news of research and discoveries from around the world.)